S 2886 New Jersey Senate · 2024-2025 Regular Session

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

This bill requires pharmacies in New Jersey to display a notice and provide a pamphlet about insulin manufacturer assistance programs at all points of sale. The materials must be created by the Department of Banking and Insurance and will be available to anyone purchasing insulin or requesting them. Insulin manufacturers offering assistance programs may request to be included in these materials. The bill directly affects pharmacies (by mandating the notices/pamphlets) and insulin users (by providing access to cost-saving program information). It does not create new programs but ensures existing manufacturer assistance options are clearly communicated to patients.
Bill status signed all 5 stages cleared
Introduction
Mar 2024
Committee Review
May 2025
Senate Passage
Feb 2025
General Assembly Passage
May 2025
Signed into Law
Jul 2025
Introduced Mar 4, 2024 Signed Jul 8, 2025
Floor votes · Senate Feb 25, 2025 · General Assembly May 22, 2025

How they voted

380
Passed · 2 other
Total votes 40
Feb 25, 2025
D Democratic25
23 Yea 2
92% Yea
R Republican15
15 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
8
Key actions
5
Committee
3
Jul 8, 2025
Signed into law
Approved P.L.2025, c.90.
executive
May 22, 2025
Lower · Passed
Passed Assembly (Passed Both Houses) (77-0-0)
lower
May 15, 2025
Lower · Passed
Reported out of Assembly Committee, 2nd Reading
lower
Feb 25, 2025
Committee
Received in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
Feb 25, 2025
Upper · Passed
Passed Senate (38-0)
upper
Feb 10, 2025
Upper · Passed
Reported out of Senate Committee with Amendments, 2nd Reading
upper
Mar 4, 2024
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
3 primary · 7 co-sponsors

Sponsors